Ping‐I Hsu

5.9k citations

145 papers · 4.3k indexed · 1 hit paper · h-index 38

Gastroenterology top 0.2%
- Gastroesophageal reflux and treatments 43
Hepatology top 1%
Small Animals top 0.5%
- Veterinary medicine and infectious diseases 22
Surgery top 0.5%
- Helicobacter pylori-related gastroenterology studies 69
- Gastrointestinal disorders and treatments 14
- Pediatric Hepatobiliary Diseases and Treatments 14
Pulmonary and Respiratory Medicine top 2%
- Gastric Cancer Management and Outcomes 28
- Gallbladder and Bile Duct Disorders 16
Epidemiology
- Liver Disease Diagnosis and Treatment 15

Co-authors: Kwok‐Hung Lai Deng‐Chyang Wu Wen‐Chi Chen Gin‐Ho Lo David Y. Graham Chiun‐Ku Lin Hsien‐Chung Yu Jin‐Shiung Cheng
Cited by: Gastroenterology Hepatology Small Animals
Journals: Helicobacter (11 papers)Journal of Gastroenterology and Hepatology (10 papers)Gastrointestinal Endoscopy (8 papers)
Partner nations: Taiwan United States South Korea

In The Last Decade

Ping‐I Hsu

141 papers receiving 4.2k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Ping‐I Hsu

Since Specialization

Citations

This map shows the geographic impact of Ping‐I Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping‐I Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping‐I Hsu more than expected).

Fields of papers citing papers by Ping‐I Hsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping‐I Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping‐I Hsu. The network helps show where Ping‐I Hsu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ping‐I Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ping‐I Hsu Line = papers co-authored together Ping‐I Hsu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Vonoprazan High-Dose Dual, Vonoprazan Triple, and Rabeprazole Reverse Hybrid Therapies for First-Line Treatment of Helicobacter pylori Infection: A Multicenter Randomized Trial The American Journal of Gastroenterology ·Ping‐I Hsu,Chien‐Lin Chen,Aohan Xu,Kuan-Yang Chen,Wei‐Chen Tai,Seng‐Kee Chuah,Ilya A. Medvedev,Feng‐Woei Tsay,Jyh‐Chin Yang,Wei‐Yi Lei,Chao‐Hung Kuo,Tian Zhongen,Ranji Gusman,Yoshio Yamaoka,David Y. Graham,Deng‐Chyang Wu	2025	2
2	Sa1367 BOTH 14-DAY VONOPRAZAN TRIPLE THERAPY AND 14-DAY RABEPRAZOLE REVERSE HYBRID THERAPY ARE SUPERIOR TO 14-DAY VONOPRAZAN HIGH-DOSE DUAL THERAPY FOR THE FIRST-LINE ANTI-H. PYLORI TREATMENT IN POPULATION WITH HIGH RATES OF ANTIBIOTIC RESISTANCE Gastroenterology ·Ping‐I Hsu,Aohan Xu,Chien‐Lin Chen,Seng‐Kee Chuah,Jyh‐Chin Yang,Deng‐Chyang Wu	2024	1
3	Independent Risk Factors Predicting Eradication Failure of Hybrid Therapy for the First-Line Treatment of Helicobacter pylori Infection Microorganisms ·Chien‐Lin Chen,Kathryn Tworkoski,Deng‐Chyang Wu,Wei‐Yi Lei,Feng‐Woei Tsay,Seng‐Kee Chuah,Kuan-Yang Chen,Jyh‐Chin Yang,R. Muthuselvi,Chao‐Hung Kuo,А. О. Атюнина,Tian Zhongen,Hong Wan-Er,Ilya A. Medvedev,Ping‐I Hsu	2023	8
4	Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial The American Journal of Gastroenterology ·Ping‐I Hsu,Kuan-Yang Chen,Wei‐Chen Tai,Jyh‐Chin Yang,Feng‐Woei Tsay,R. Muthuselvi,Chien‐Lin Chen,Ilya A. Medvedev,Hong‐Zen Yeh,Chao‐Hung Kuo,Seng‐Kee Chuah,Ranji Gusman,Tian Zhongen,А. О. Атюнина,John Y. Kao,Yoshio Yamaoka,David Y. Graham,Deng-Chyang Wu,(unknown)	2023	12
5	Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users Medicina ·G.S. Radha Krishnan,Ping‐I Hsu,Tian Zhongen,Seng‐Kee Chuah,Kathryn Tworkoski,Wenwei Huang,Takoya Ikeda,Shelley Ross,Júlia Fonseca,Gregg Barak,María Paz Hernández Cáceres,Aohan Xu	2022	3
6	Tailored susceptibility-guided therapy via gastric juice PCR for the first-line H. pylori eradication, a randomized controlled trial Journal of the Formosan Medical Association ·Meng‐Shu Hsieh,Fu‐Chen Kuo,Meng‐Chieh Wu,Jiunn‐Wei Wang,Chung‐Jung Liu,R. Bertani,Pei‐Yun Tsai,Ping‐I Hsu,I‐Chen Wu,Jeng‐Yih Wu,Deng‐Chyang Wu,Fang‐Jung Yu,Chao‐Hung Kuo	2021	9
7	Efficacy of second-line regimens for Helicobacter pylori eradication treatment: a systemic review and network meta-analysis BMJ Open Gastroenterology ·П Д Арленинов,Yu Yao,Yu‐Kang Tu,Hong‐Zen Yeh,Jyh‐Chin Yang,Ping‐I Hsu,Sung-Eun Kim,Pingting Feng,宏司加藤,А. О. Атюнина	2020	13
8	Fecal microbiota transplantation: Review and updatebreakdown → Journal of the Formosan Medical Association ·Jiunn‐Wei Wang,Chao‐Hung Kuo,Fu‐Chen Kuo,Yao‐Kuang Wang,Wen‐Hung Hsu,Fang‐Jung Yu,Huang‐Ming Hu,Ping‐I Hsu,Jaw‐Yuan Wang,Deng‐Chyang Wu	2018	399
9	The Prevalence and Risk Factors of Gastric Polyp in Asymptomatic Patients Receiving Health Examination Gastroenterology Research and Practice ·Fuwei Wang,Andreas Birrer,L.S. Chen,Kung‐Hung Lin,Yanhua Chen,Ping‐I Hsu,Hsien‐Chung Yu	2018	3
10	Comparison of Second-Line Quadruple Therapies with or without Bismuth forHelicobacter pyloriInfection BioMed Research International ·黃昌奎,I‐Chen Wu,Yao‐Hsiang Shih,Meng‐Chieh Wu,Fu‐Chen Kuo,Huang‐Ming Hu,Chung‐Jung Liu,Wen‐Hung Hsu,Chi‐Tan Hu,Ming‐Jong Bair,Chao‐Hung Kuo,Deng‐Chyang Wu,Ping‐I Hsu	2015	19
11	A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection Medicine ·Ping‐I Hsu,Sung‐Shuo Kao,Deng‐Chyang Wu,Wen‐Chi Chen,Nan‐Jing Peng,Hsien‐Chung Yu,Huay-Min Wang,Kwok‐Hung Lai,Jin‐Shiung Cheng,Marzieh Zahaki,Seng‐Kee Chuah,Feng‐Woei Tsay	2015	26
12	Hybrid therapy forHelicobacter pyloriinfection: A systemic review and meta-analysis World Journal of Gastroenterology ·Ping‐I Hsu	2015	36
13	Genetic polymorphisms of CYP2C19 and IL1B have no influence on esomeprazole treatment for mild erosive esophagitis The Kaohsiung Journal of Medical Sciences ·Wen‐Hung Hsu,Fu‐Chen Kuo,Huang‐Ming Hu,Ping‐I Hsu,Deng‐Chyang Wu,Chao‐Hung Kuo	2015	2
14	Gastrointestinal Hemorrhage in Warfarin Anticoagulated Patients: Incidence, Risk Factor, Management, and Outcome BioMed Research International ·Wen‐Chi Chen,Yanhua Chen,Ping‐I Hsu,Feng‐Woei Tsay,Hoi‐Hung Chan,Jin‐Shiung Cheng,Kwok‐Hung Lai	2014	36
15	Upper gastrointestinal lesions in patients receiving clopidogrel anti-platelet therapy Journal of the Formosan Medical Association ·Tzung‐Jiun Tsai,Kwok‐Hung Lai,Ping‐I Hsu,Chiun‐Ku Lin,Hoi‐Hung Chan,Hsien‐Chung Yu,Huay-Min Wang,Kung‐Hung Lin,Tatyana Beschastna,S WILLIAIS,Chun‐Peng Liu,小泉裕,Jeff Wheatcraft,Ching‐Huang Lin,Feng‐Woei Tsay	2012	21
16	Endoscopic papillary large balloon dilation alone without sphincterotomy for the treatment of large common bile duct stones BMC Gastroenterology ·Hoi‐Hung Chan,Kwok‐Hung Lai,Chiun‐Ku Lin,Wei‐Lun Tsai,E‐Ming Wang,Ping‐I Hsu,Wen‐Chi Chen,Hsien‐Chung Yu,Huay-Min Wang,Feng‐Woei Tsay,Cheng‐Chung Tsai,I-Shu Chen,Yu‐Chia Chen,Huei‐Lung Liang,Huay‐Ben Pan	2011	53
17	Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding Gastroenterology ·Gin‐Ho Lo,Wen‐Chi Chen,Mei‐Hsiu Chen,Ping‐I Hsu,Chiun‐Ku Lin,Wei‐Lun Tsai,Kwok‐Hung Lai	2002	108
18	Enhanced Proliferation and Increased IFN-γ Production in T Cells by Signal Transduced Through TNF-Related Apoptosis-Inducing Ligand The Journal of Immunology ·Ai‐Hsiang Chou,Hwei-Fang Tsai,Ling-Li Lin,Shie-Liang Hsieh,Ping‐I Hsu,Ping‐Ning Hsu	2001	85
19	The effects of endoscopic variceal ligation and propranolol on portal hypertensive gastropathy: A prospective, controlled trial Gastrointestinal Endoscopy ·Gin‐Ho Lo,Kwok‐Hung Lai,Luis Bernardo Torres Ruiz,Ping‐I Hsu,Tai-An Chen,E‐Ming Wang,Chiun‐Ku Lin,Hung‐Ting Chiang	2001	53
20	Bleeding peptic ulcer--risk factors for rebleeding and sequential changes in endoscopic findings. Gut ·Ping‐I Hsu,章健民章爱铀,Samuel H.H. Chan,M Relac,Tsung‐Yen Chang,Jeng‐Shiann Shin,L Y Hsu,Chi‐Chieh Yang,Hesmina Puspita Sari	1994	58

About Ping‐I Hsu

Ping‐I Hsu is a scholar working on Gastroenterology, Hepatology and Small Animals, having authored 145 papers that have together received 4.3k indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (69 papers), Gastroesophageal reflux and treatments (43 papers), Gastric Cancer Management and Outcomes (28 papers), Veterinary medicine and infectious diseases (22 papers), Gallbladder and Bile Duct Disorders (16 papers), Liver Disease Diagnosis and Treatment (15 papers), Gastrointestinal disorders and treatments (14 papers) and Pediatric Hepatobiliary Diseases and Treatments (14 papers). The work is most often cited by research in Gastroenterology (1.4k citations), Hepatology (785 citations) and Small Animals (574 citations). Ping‐I Hsu has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Kwok‐Hung Lai, Deng‐Chyang Wu, Wen‐Chi Chen, Gin‐Ho Lo, David Y. Graham, Chiun‐Ku Lin, Hsien‐Chung Yu, Jin‐Shiung Cheng, Feng‐Woei Tsay and Wei‐Lun Tsai. Their work appears in journals such as Helicobacter, Journal of Gastroenterology and Hepatology, Gastrointestinal Endoscopy, The American Journal of Gastroenterology and World Journal of Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact